Literature DB >> 27394189

2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.

.   

Abstract

Entities:  

Keywords:  AHA Scientific Statements; angioedema; angiotensin receptor blockers; angiotensin receptor-neprilysin inhibitor; angiotensin-converting enzyme inhibitors; beta blockers; focused update; heart failure; ivabradine; natriuretic peptides

Mesh：

Year:  2016        PMID： 27394189     DOI： 10.1016/j.cardfail.2016.07.001

Source DB:  PubMed          Journal:  J Card Fail        ISSN： 1071-9164            Impact factor:   5.712


× No keyword cloud information.
  22 in total

1.  Erratum to: Clinical Pharmacokinetics of Sacubitril/Valsartan (LCZ696): A Novel Angiotensin Receptor-Neprilysin Inhibitor.

Authors:  Surya Ayalasomayajula; Thomas Langenickel; Parasar Pal; Sreedevi Boggarapu; Gangadhar Sunkara
Journal:  Clin Pharmacokinet       Date:  2018-01       Impact factor: 6.447

Review 2.  Heart failure in the elderly: ten peculiar management considerations.

Authors:  Feras Bader; Bassam Atallah; Lisa F Brennan; Rola H Rimawi; Mohammed E Khalil
Journal:  Heart Fail Rev       Date:  2017-03       Impact factor: 4.214

Review 3.  Clinical Pharmacokinetics of Sacubitril/Valsartan (LCZ696): A Novel Angiotensin Receptor-Neprilysin Inhibitor.

Authors:  Surya Ayalasomayajula; Thomas Langenickel; Parasar Pal; Sreedevi Boggarapu; Gangadhar Sunkara
Journal:  Clin Pharmacokinet       Date:  2017-12       Impact factor: 6.447

4.  AI Based CMR Assessment of Biventricular Function: Clinical Significance of Intervendor Variability and Measurement Errors.

Authors:  Shuo Wang; Hena Patel; Tamari Miller; Keith Ameyaw; Akhil Narang; Daksh Chauhan; Simran Anand; Emeka Anyanwu; Stephanie A Besser; Keigo Kawaji; Xing-Peng Liu; Roberto M Lang; Victor Mor-Avi; Amit R Patel
Journal:  JACC Cardiovasc Imaging       Date:  2021-10-13

5.  Implantable vagus nerve stimulation system performance is not affected by internal or external defibrillation shocks.

Authors:  Imad Libbus; Scott R Stubbs; Scott T Mazar; Scott Mindrebo; Bruce H KenKnight; Lorenzo A DiCarlo
Journal:  J Interv Card Electrophysiol       Date:  2021-08-31       Impact factor: 1.759

6.  Effect of an Early Palliative Care Telehealth Intervention vs Usual Care on Patients With Heart Failure: The ENABLE CHF-PC Randomized Clinical Trial.

Authors:  Marie A Bakitas; J Nicholas Dionne-Odom; Deborah B Ejem; Rachel Wells; Andres Azuero; Macy L Stockdill; Konda Keebler; Elizabeth Sockwell; Sheri Tims; Sally Engler; Karen Steinhauser; Elizabeth Kvale; Raegan W Durant; Rodney O Tucker; Kathryn L Burgio; Jose Tallaj; Keith M Swetz; Salpy V Pamboukian
Journal:  JAMA Intern Med       Date:  2020-09-01       Impact factor: 21.873

Review 7.  Muscle wasting and cachexia in heart failure: mechanisms and therapies.

Authors:  Stephan von Haehling; Nicole Ebner; Marcelo R Dos Santos; Jochen Springer; Stefan D Anker
Journal:  Nat Rev Cardiol       Date:  2017-04-24       Impact factor: 32.419

Review 8.  Addressing the Heterogeneity of Heart Failure in Future Randomized Trials.

Authors:  Annamaria Iorio; Andrea Pozzi; Michele Senni
Journal:  Curr Heart Fail Rep       Date:  2017-06

9.  The association between high-dose loop diuretic use at discharge and cardiovascular mortality in patients with heart failure.

Authors:  Toshitaka Okabe; Tadayuki Yakushiji; Takehiko Kido; Yuji Oyama; Wataru Igawa; Morio Ono; Seitaro Ebara; Kennosuke Yamashita; Myong Hwa Yamamoto; Shigeo Saito; Kisaki Amemiya; Naoei Isomura; Masahiko Ochiai
Journal:  ESC Heart Fail       Date:  2017-10-02

10.  Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction.

Authors:  Michael Coll Barroso; Philip Boehme; Frank Kramer; Thomas Mondritzki; Till Koehler; Jan-Erik Gülker; Martin Karoff; Wilfried Dinh
Journal:  Arq Bras Cardiol       Date:  2017-09-28       Impact factor: 2.000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.